5 Key Takeaways

• 1

  Researchers quantified boron levels in individual live cancer cells using single-cell ICP-MS for the first time.

• 2

  The study focuses on boron neutron capture therapy (BNCT) for targeted treatment of head and neck cancer.

• 3

  Single-cell ICP-MS allows real-time measurement of boron uptake and retention in individual cells.

• 4

  Results indicated that BPA uptake was rapid, while BSH entered cells more slowly and inconsistently.

• 5

  The research provides insights into boron transport pathways, aiding in the design of more effective boron-based therapies.